These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26882038)

  • 1. AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers.
    Morgan CJ; Freeman TP; Powell J; Curran HV
    Transl Psychiatry; 2016 Feb; 6(2):e738. PubMed ID: 26882038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].
    Morgan CJ; Schafer G; Freeman TP; Curran HV
    Br J Psychiatry; 2010 Oct; 197(4):285-90. PubMed ID: 20884951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users.
    Di Forti M; Iyegbe C; Sallis H; Kolliakou A; Falcone MA; Paparelli A; Sirianni M; La Cascia C; Stilo SA; Marques TR; Handley R; Mondelli V; Dazzan P; Pariante C; David AS; Morgan C; Powell J; Murray RM
    Biol Psychiatry; 2012 Nov; 72(10):811-6. PubMed ID: 22831980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Single Nucleotide Polymorphisms in Catechol-O-Methyltransferase and Serine-Threonine Protein Kinase Genes in the Pakistani Schizophrenic Population: A Study with Special Emphasis on Cannabis and Smokeless Tobacco.
    Nawaz R; Siddiqui S
    CNS Neurol Disord Drug Targets; 2015; 14(8):1086-95. PubMed ID: 25801838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
    Hindocha C; Quattrone D; Freeman TP; Murray RM; Mondelli V; Breen G; Curtis C; Morgan CJA; Valerie Curran H; Di Forti M
    Transl Psychiatry; 2020 May; 10(1):143. PubMed ID: 32398646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
    van Winkel R; van Beveren NJ; Simons C;
    Neuropsychopharmacology; 2011 Nov; 36(12):2529-37. PubMed ID: 21775978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Nieman DH; Dragt S; van Duin EDA; Denneman N; Overbeek JM; de Haan L; Rietdijk J; Ising HK; Klaassen RMC; van Amelsvoort T; Wunderink L; van der Gaag M; Linszen DH
    Schizophr Res; 2016 Jul; 174(1-3):24-28. PubMed ID: 27052366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the
    Fatjó-Vilas M; Soler J; Ibáñez MI; Moya-Higueras J; Ortet G; Guardiola-Ripoll M; Fañanás L; Arias B
    J Psychopharmacol; 2020 Sep; 34(9):990-998. PubMed ID: 32536252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis and a lower BMI in psychosis: What is the role of AKT1?
    Liemburg EJ; Bruins J; van Beveren N; Islam MA; Alizadeh BZ;
    Schizophr Res; 2016 Oct; 176(2-3):95-99. PubMed ID: 27554198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
    Morgan CJ; Gardener C; Schafer G; Swan S; Demarchi C; Freeman TP; Warrington P; Rupasinghe I; Ramoutar A; Tan N; Wingham G; Lewis S; Curran HV
    Psychol Med; 2012 Feb; 42(2):391-400. PubMed ID: 21798112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use, COMT, BDNF and age at first-episode psychosis.
    Mané A; Bergé D; Penzol MJ; Parellada M; Bioque M; Lobo A; González-Pinto A; Corripio I; Cabrera B; Sánchez-Torres AM; Saiz-Ruiz J; Bernardo M;
    Psychiatry Res; 2017 Apr; 250():38-43. PubMed ID: 28142064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
    Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.
    Vinkers CH; Van Gastel WA; Schubart CD; Van Eijk KR; Luykx JJ; Van Winkel R; Joëls M; Ophoff RA; Boks MP; ; Bruggeman R; Cahn W; de Haan L; Kahn RS; Meijer CJ; Myin-Germeys I; van Os J; Wiersma D
    Schizophr Res; 2013 Oct; 150(1):303-11. PubMed ID: 23954148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes.
    Alemany S; Arias B; Fatjó-Vilas M; Villa H; Moya J; Ibáñez MI; Ortet G; Gastó C; Fañanás L
    Acta Psychiatr Scand; 2014 Jan; 129(1):54-62. PubMed ID: 23445265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis, COMT and psychotic experiences.
    Zammit S; Owen MJ; Evans J; Heron J; Lewis G
    Br J Psychiatry; 2011 Nov; 199(5):380-5. PubMed ID: 21947654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.
    Morgan CJ; Freeman TP; Schafer GL; Curran HV
    Neuropsychopharmacology; 2010 Aug; 35(9):1879-85. PubMed ID: 20428110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
    Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D
    J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?
    Curran HV; Hindocha C; Morgan CJA; Shaban N; Das RK; Freeman TP
    Psychol Med; 2019 Jul; 49(9):1574-1580. PubMed ID: 30176957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms.
    Carvalho C; Vieira-Coelho MA
    Pharmacol Res; 2022 Jul; 181():106258. PubMed ID: 35588917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.